Publikationen der letzten 5 Jahre
2025
Fundus autofluorescence intensity, lifetime, and spectral imaging in age-related macular degeneration. Hammer M, Oertel J, Alderzy H, Tarhan M, Meller D, Curcio C. Exp Eye Res. 2025 Jun 26: 110500. doi: 10.1016/j.exer.2025.110500. PMID: 40581140 ReviewFundus autofluorescence lifetimes in age-related macular degeneration versus healthy controls in a pseudophakic population. Oertel J, Fischer D, Tarhan M, Meller D, Hammer M. Acta Ophthalmol. 2025 May 14. doi: 10.1111/aos.17519. PMID: 40365784Fluorescence Lifetime Imaging Ophthalmoscopy, Vision, and Chorioretinal Asymmetries in Aging and Age-Related Macular Degeneration: ALSTAR2. Goerdt L, Clark ME, Thomas TN, Gao L, McGwin G Jr, Hammer M, Crosson JN, Sloan KR, Owsley C, Curcio CA. Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):56. doi: 10.1167/iovs.66.4.56. PMID: 40257785Hyperautofluorescent material inside areas of macular atrophy may reveal non-lipofuscin fluorophores in late stage AMD. Tarhan M, Meller D, Hammer M. Acta Ophthalmol. 2025 Feb;103(1):e66-e75. doi: 10.1111/aos.16752. PMID: 39177106
2024
Repeatability and reliability of choriocapillaris flow deficit measurement by spectral-domain OCTA. Tarhan M, Lehmann T, Meller D, Hammer M. Graefes Arch Clin Exp Ophthalmol. 2024 Jun; 262(6): 1945-1947. doi: 10.1007/s00417-024-06423-y. PMID: 38416234Subretinal drusenoid deposits, age-related macular degeneration, and cardiovascular disease. Smith RT, Olsen TW, Chong V, Kim J, Hammer M, Lema G, Deobhakta A, Tan A, Tong Y, Tai K, Fei Y, Mordechaev E, Ledesma-Gil G, Otero-Marquez O, Rosen RB, Bhuiyan A, Sivaprasad S, Rosenfeld PJ. Asia Pac J Ophthalmol (Phila). 2024 Jan-Feb; 13(1): 100036. doi: 10.1016/j.apjo.2024.100036. PMID: 38244930
2022
Fluorescence Lifetime and Spectral Characteristics of Subretinal Drusenoid Deposits and Their Predictive Value for Progression of Age-Related Macular Degeneration. Weber S, Simon R, Schwanengel LS, Curcio CA, Augsten R, Meller D, Hammer M. Invest Ophthalmol Vis Sci. 2022 Dec 1; 63(13): 23. doi: 10.1167/iovs.63.13.23. PMID: 36580310Prolonged Lifetimes of Histologic Autofluorescence in Ectopic Retinal Pigment Epithelium in Age-Related Macular Degeneration. Simon R, Jentsch M, Karimimousivandi P, Cao D, Messinger JD, Meller D, Curcio CA, Hammer M. Invest Ophthalmol Vis Sci. 2022 Dec 1; 63(13): 5. doi: 10.1167/iovs.63.13.5. PMID: 36469025Combining fluorescence lifetime with spectral information in fluorescence lifetime imaging ophthalmoscopy (FLIO). Hammer M, Simon R, Meller D, Klemm M. Biomed Opt Express. 2022 Sep 26; 13(10): 5483-5494. doi: 10.1364/BOE.457946. eCollection 2022 Oct 1. PMID: 36425633Optic disc blood perfusion and oxygenation in glaucoma. Al Zoubi H, Riemer T, Simon R, Vilser W, Hasan S, Meller D, Augsten R, Hammer M. Graefes Arch Clin Exp Ophthalmol. 2022 Nov; 260(11): 3587-3595. doi: 10.1007/s00417-022-05722-6. PMID: 35666297Spectral fundus autofluorescence peak emission wavelength in ageing and AMD. Schultz R, Schwanengel L, Klemm M, Meller D, Hammer M. Acta Ophthalmol. 2022 Sep;100(6):e1223-e1231. doi: 10.1111/aos.15070. PMID: 34850573Fluorescence lifetime and peak emission wavelength differ between AMD patients with soft drusen and sub-retinal drusenoid deposits. Simon R, Curcio CA, Weber S, Meller D, Hammer M. Acta Ophthalmol. 2022 Sep; 100(6): e1354-e1355. doi: 10.1111/aos.15087. PMID: 35060686Impact of cataract on the spectral measurement of fundus autofluorescence. Simon R, Brauer JL, Meller D, Hammer M. Graefes Arch Clin Exp Ophthalmol. 2022 Jun; 260(6): 2057-2059. doi: 10.1007/s00417-022-05554-4. PMID: 35020017Spectral and lifetime resolution of fundus autofluorescence in advanced age-related macular degeneration revealing different signal sources. Schultz R, Hasan S, Curcio CA, Smith RT, Meller D,Hammer M.Acta Ophthalmol. 2022 May; 100(3):e841-e846. doi: 10.1111/aos.14963. PMID: 34258885Spectral calibration of fluorescence lifetime imaging ophthalmoscopy. Schultz R, Klemm M, Meller D, Hammer M. Acta Ophthalmol. 2022 Mar;100(2): e612-e613. doi: 10.1111/aos.14950. PMID: 34155815Changes of retinal oxygen saturation during treatment of diabetic macular edema with a pre-defined regimen of aflibercept: a prospective study. Hasan SM, Hammer M, Meller D. Graefes Arch Clin Exp Ophthalmol. 2022 Feb; 260(2): 451-457. doi: 10.1007/s00417-021-05319-5. PMID: 34468834
2021
Progressive Dysmorphia of Retinal Pigment Epithelium in Age-Related Macular Degeneration Investigated by Fluorescence Lifetime Imaging. Hammer M, Jakob-Girbig J, Schwanengel L, Curcio CA, Hasan S, Meller D, Schultz R. Invest Ophthalmol Vis Sci. 2021 Sep 2; 62(12): 2. doi: 10.1167/iovs.62.12.2. PMID: 34491262Fluorescence lifetimes increase over time in age-related macular degeneration. Schultz R, Hasan S, Schwanengel LS, Hammer M. Acta Ophthalmol. 2021 Sep; 99(6):e970-e972. doi: 10.1111/aos.14694. PMID: 33342081Enrichment and characterization of extracellular vesicles from ex vivo one-sided human placenta perfusion. Zabel RR, Bär C, Ji J, Schultz R, Hammer M, Groten T, Schleussner E, Morales-Prieto DM, Markert UR, Favaro RR. Am J Reprod Immunol. 2021 Aug; 86(2): e13377. doi: 10.1111/aji.13377. PMID: 33175429
2020
Fluorescence Lifetimes and Spectra of RPE and Sub-RPE Deposits in Histology of Control and AMD Eyes. Schultz R, Gamage KCLK, Messinger JD, Curcio CA, Hammer M. Invest Ophthalmol Vis Sci. 2020 Sep 1; 61(11) :9. doi: 10.1167/iovs.61.11.9.PMID: 32897378Influence of Lens Fluorescence on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Fundus Imaging and Strategies for Its Compensation. Brauer JL, Schultz R, Klemm M, Hammer M. Transl Vis Sci Technol. 2020 Jul 9; 9(8): 13. doi: 10.1167/tvst.9.8.13. eCollection 2020 Jul. PMID: 32855860Fundus Autofluorescence Lifetimes and Spectral Features of Soft Drusen and Hyperpigmentation in Age-Related Macular Degeneration. Hammer M, Schultz R, Hasan S, Sauer L, Klemm M, Kreilkamp L, Zweifel L, Augsten R, Meller D. Transl Vis Sci Technol. 2020 Apr 24; 9(5): 20. doi: 10.1167/tvst.9.5.20. eCollection 2020 Apr. PMID: 32821492
